MIRM icon

Mirum Pharmaceuticals
MIRM

Overview Fund Activity

145 hedge funds and large institutions have $956M invested in Mirum Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 58 increasing their positions, 28 reducing their positions, and 9 closing their positions.

Holders
145
Holders Change
+29
Holders Change %
+25%
% of All Funds
2.29%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
38
Increased
58
Reduced
28
Closed
9
Calls
$486K
Puts
$1.33M
Net Calls
-$846K
Net Calls Change
-$11.1M

Top Buyers

1
EAM
1
Eventide Asset Management
Massachusetts
$89.5M
2
NIP
2
Nicholas Investment Partners
California
$23.7M
3
CCM
3
Cadian Capital Management
New York
$32.7M
4
FLSM
4
Frazier Life Sciences Management
California
$113M
5
William Blair Investment Management
5
William Blair Investment Management
Illinois
$8.73M

Top Sellers

1
NMC
1
NEA Management Company
Maryland
$56.6M
2
DM
2
Deerfield Management
New York
$0
3
Axa
3
Axa
France
$17.3M
4
WP
4
Woodline Partners
California
$8.48M
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Northern Trust
26
Northern Trust
Illinois
$7.08M +$1.54M +59,662 +28%
Janus Henderson Group
27
Janus Henderson Group
United Kingdom
$6.86M +$5.8M +224,328 +543%
Jane Street
28
Jane Street
New York
$6.41M +$5.24M +202,379 +447%
PCM
29
Penn Capital Management
Pennsylvania
$6.19M +$6.19M +239,274 New
SAM
30
Silvercrest Asset Management
New York
$6.06M +$851K +32,888 +16%
WA
31
Wasatch Advisors
Utah
$5.96M +$5.96M +230,461 New
Ensign Peak Advisors
32
Ensign Peak Advisors
Utah
$5.84M – – –
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$5.41M +$5.1M +197,154 +1,630%
SCM
34
Soleus Capital Management
Connecticut
$4.55M -$1.71M -66,000 -27%
HP
35
Highlander Partners
Texas
$3.18M – – –
Rafferty Asset Management
36
Rafferty Asset Management
New York
$3M +$769K +29,732 +35%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$2.9M +$1.35M +52,333 +87%
Deutsche Bank
38
Deutsche Bank
Germany
$2.88M +$1.24M +48,020 +76%
UBS Group
39
UBS Group
Switzerland
$2.86M +$1.81M +70,080 +173%
SCM
40
Silverarc Capital Management
Massachusetts
$2.75M +$11.3K +436 +0.4%
Morgan Stanley
41
Morgan Stanley
New York
$2.7M +$1.56M +60,285 +136%
Two Sigma Investments
42
Two Sigma Investments
New York
$2.67M +$2.67M +103,110 New
T. Rowe Price Associates
43
T. Rowe Price Associates
Maryland
$2.58M +$2.27M +87,753 +736%
Bank of America
44
Bank of America
North Carolina
$2.19M -$547K -21,128 -20%
Nuveen Asset Management
45
Nuveen Asset Management
Illinois
$1.96M +$101K +3,906 +5%
Charles Schwab
46
Charles Schwab
California
$1.87M +$506K +19,545 +37%
SAM
47
Simplify Asset Management
Nevada
$1.81M – – –
RJA
48
Raymond James & Associates
Florida
$1.75M +$1.01M +39,001 +136%
IBT
49
International Biotechnology Trust
United Kingdom
$1.74M – – –
PAI
50
Palo Alto Investors
California
$1.67M – – –
1
2
3 4 5